Please assess the completion status of the following clinical trial:

Trial Title: Multicenter, Nonrandomized, Prospective Study of Pulmonary Embolism Removal With the AngioJet 6F Ultra System

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Symptomatic pulmonary embolism patients \>18 years~2. Availability of a baseline contrast-enhanced chest computed tomogram or conventional pulmonary angiogram with evidence of pulmonary embolus in at least one main or lobar pulmonary artery ≥ 6mm in diameter~3. Availability of a baseline transthoracic echocardiogram with sufficient image quality permitting the measurement of right ventricular (RV) and left ventricular (LV) dimensions in the apical or subcostal four-chamber view~4. Echocardiographic evidence of right ventricular dilatation with a subannular RV/LV ratio ≥ 0.9 from the apical or subcostal four-chamber view~5. Appropriate informed consent was obtained from the patient or legal representative~Exclusion Criteria:~1. Patient has underwent Cardiopulmonary Resuscitation (CPR) in the last 48 hours~2. Patient is participating in any other clinical study~3. Pregnancy, lactation or parturition within the previous 30 days (positive pregnancy test, women of childbearing age must be tested or use a medically accepted method of birth control)~4. Inability to comply with study Follow-up assessments (e.g. due to geographic)~5. Previous enrollment in this study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- AngioJet Ultra PE Thrombectomy System (Type: EXPERIMENTAL): Patients are treated with the AngioJet Ultra PE Thrombectomy System

Based on this trial design, predict the completion outcome and termination type (if applicable).